Oncology Corporate Profile
PDS Biotechnology Corporation is a biopharmaceutical company pioneering the development of safe, simple, potent and targeted immunotherapies for the treatment of cancer and infectious diseases. Unlike typical cancer and antiviral immunotherapies, PDS's patented nanoparticle technology both facilitates the uptake of disease-associated proteins and peptides by the cells of the immune system and simultaneously activates the immune system to generate a strong and specific immune response against the infected cells in the body, resulting in eradication of the cancer or viral disease.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|Versamune®||immunotherapy (nanoparticle)||Cervical cancer||Preclinical|
|Versamune®||immunotherapy (nanoparticle)||Head & Neck cancer||Preclinical|
View additional information on product candidates here »